Avantor, Inc. (NYSE:AVTR) Receives $10.62 Consensus Price Target from Brokerages

Shares of Avantor, Inc. (NYSE:AVTR) have been given an average recommendation of “Reduce” by the seventeen analysts that are covering the firm, MarketBeat Ratings reports. Three research analysts have rated the stock with a sell rating, twelve have issued a hold rating and two have given a buy rating to the company. The average 1-year target price among brokers that have covered the stock in the last year is $10.6250.

Several brokerages have recently issued reports on AVTR. UBS Group set a $8.00 target price on Avantor in a research report on Wednesday, June 24th. Wolfe Research downgraded shares of Avantor to an “underperform” rating and set a $7.00 price target on the stock. in a report on Monday, June 1st. Barclays increased their price target on shares of Avantor from $7.00 to $8.00 and gave the company an “underweight” rating in a research report on Wednesday, June 24th. Citigroup raised their price objective on shares of Avantor from $9.00 to $11.00 and gave the stock a “neutral” rating in a report on Wednesday, July 8th. Finally, Royal Bank Of Canada initiated coverage on shares of Avantor in a research report on Thursday, May 14th. They issued a “sector perform” rating and a $9.00 price objective on the stock.

Insider Activity at Avantor

In other news, Director Gregory T. Lucier purchased 10,000 shares of the company’s stock in a transaction dated Friday, May 8th. The shares were purchased at an average price of $8.32 per share, with a total value of $83,200.00. Following the transaction, the director directly owned 60,000 shares of the company’s stock, valued at approximately $499,200. This represents a 20.00% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Simon Dingemans purchased 25,000 shares of the company’s stock in a transaction dated Friday, May 1st. The shares were purchased at an average cost of $8.14 per share, for a total transaction of $203,500.00. Following the transaction, the director directly owned 25,000 shares in the company, valued at approximately $203,500. The trade was a ∞ increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Company insiders own 0.28% of the company’s stock.

Institutional Investors Weigh In On Avantor

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. EverSource Wealth Advisors LLC increased its stake in shares of Avantor by 119.1% in the second quarter. EverSource Wealth Advisors LLC now owns 2,187 shares of the company’s stock worth $29,000 after purchasing an additional 1,189 shares in the last quarter. Private Trust Co. NA lifted its stake in shares of Avantor by 46.2% during the 4th quarter. Private Trust Co. NA now owns 2,769 shares of the company’s stock valued at $32,000 after buying an additional 875 shares in the last quarter. Strategic Wealth Investment Group LLC purchased a new stake in shares of Avantor during the 2nd quarter valued at approximately $32,000. Los Angeles Capital Management LLC bought a new position in Avantor in the 4th quarter worth approximately $32,000. Finally, Osaic Holdings Inc. boosted its holdings in Avantor by 60.9% in the 2nd quarter. Osaic Holdings Inc. now owns 2,810 shares of the company’s stock worth $38,000 after buying an additional 1,064 shares during the period. 95.08% of the stock is currently owned by institutional investors.

Avantor Stock Performance

AVTR stock opened at $12.44 on Friday. The firm has a market cap of $8.49 billion, a PE ratio of -15.35, a P/E/G ratio of 6.55 and a beta of 0.94. The company has a quick ratio of 1.17, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. The business has a 50 day moving average of $9.89 and a 200-day moving average of $9.39. Avantor has a 12-month low of $7.26 and a 12-month high of $15.93.

Avantor (NYSE:AVTR) last issued its quarterly earnings results on Wednesday, April 29th. The company reported $0.17 EPS for the quarter, beating analysts’ consensus estimates of $0.16 by $0.01. Avantor had a positive return on equity of 9.95% and a negative net margin of 8.42%.The company had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.54 billion. During the same period last year, the business posted $0.23 earnings per share. Avantor’s revenue was up .0% on a year-over-year basis. As a group, sell-side analysts expect that Avantor will post 0.79 earnings per share for the current year.

Avantor Company Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.